Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
AstraZeneca
Mallinckrodt
Merck
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Ammonium chloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ammonium chloride and what is the scope of patent protection?

Ammonium chloride is the generic ingredient in four branded drugs marketed by Abbott, Gd Searle Llc, Mcgaw, B Braun, and Hospira, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for ammonium chloride.

Summary for ammonium chloride
Recent Clinical Trials for ammonium chloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Mercy Hospital Kansas CityPhase 1
American Heart AssociationPhase 1
University Hospitals Cleveland Medical CenterN/A

See all ammonium chloride clinical trials

US Patents and Regulatory Information for ammonium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun AMMONIUM CHLORIDE 2.14% ammonium chloride INJECTABLE;INJECTION 085734-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Gd Searle Llc AMMONIUM CHLORIDE ammonium chloride INJECTABLE;INJECTION 086205-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira AMMONIUM CHLORIDE IN PLASTIC CONTAINER ammonium chloride INJECTABLE;INJECTION 088366-001 Jun 13, 1984 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Colorcon
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.